IL1B and Alzheimer disease: GSDMD activation in the spleen was further up-regulated by LPS administration (Fig. 7c–e), and the level of IL-1β in brain specimens of 5 × FAD mice also increased after challenge, suggesting that peripherally activated GSDMD influences the brain in AD mice (Fig. 7b).